No Detail Found!

Effectiveness of platelet-rich plasma gel alongside tacrolimus ointment in managing erosive oral lichen planus and its effect on oral immune microenvironment

Author(s)
Chao Huang Department of Stomatology, Huaibei Miners General Hospital,Huaibei, Anhui Province,China
Fang Li Department of Stomatology, Huaibei Miners General Hospital,Huaibei, Anhui Province,China
Abstract
Oral lichen planus (OLP) is an autoimmune disease that significantly impacting patients' life quality. To investigate the clinical efficacy of platelet-rich plasma (PRP) gel coupled with tacrolimus ointment in managing erosive oral lichen planus (EOLP) and its effect on the oral immune environment, 80 EOLP patients were selected from 2021 to 2023 and randomised to two groups in our hospital. Both groups were given tacrolimus ointment, the study group added PRP gel. Comparative analysis of lesion area scores and overall treatment effects, wound pain index, salivary inflammatory factors and CD3+, CD4+, CD8+, CD4+/CD8+ ratio, immunoglobulin M (IgM) Changes, adverse reactions and relapses records. After treatment, compared to the control group, the overall effective rate of the study group was significantly higher, the lesion area and VAS score decreased, inflammatory factors decreased, and immune indexes improved (elevated CD3+, CD4+ and CD4+/CD8+ and a decrease in CD8+ and IgM) (P<0.05). Neither of them with serious adverse reactions (P>0.05). The study group's recurrence rate was lower than the control group's (P<0.05). This study demonstrated that PRP gel combined with tacrolimus ointment is superior to tacrolimus ointment alone for the treatment of EOLP and can be further applied to clinical treatment.
Publication Details
Page(s) 1625-1633
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
Immunization, Tacrolimus ointment, erosive oral lichen planus, Platelet-rich plasma gel
References
Afzali S,Mohammad isoleimani E,Mansoori Y,Mohaghegh P,Bahmanyar M,Mansoori B,Pezeshki B,Nikfar G,Tavassoli A,Shahi A,Moravej A .2023 .The potential roles of Th17 cells in the pathogenesis of oral lichen planus. Inflamm Res., 72(7) : 1513-1524.
Al-Hallak N,Hamadah O,Mouhamad M,Kujan O M .2023 .Efficacy of injectable platelet-rich fibrin in the treatment of symptomatic oral lichen planus. Oral Dis, 29(5) : 2256-2264.
Alarcon-Sanchez M A,Becerra-Ruiz J S A,Heboyan A .2024 .Activity and levels of TNF-α, IL-6 and IL-8 in saliva of children and young adults with dental caries: A systematic review and meta-analysis. BMC Oral Health, 24(1) : 816.
Almutairi M,Riyaz SSMA,Awinashe M,Almutairi FJ .2023 .Assessment of 5% amlexanox, 0.1% triamcinolone acetonide and 0.03% tacrolimus in the management of oral lichen planus. J. Pharm. Bioallied Sci., 15(Suppl 2) : S1298-S1300.
Anitua E,Eguia A,Alkhraisat MH,Piñas L MH .2022 .Oral lichen planus treated with plasma rich in growth factors. Cutis, 109(3) : 163-166.
Arana A,Pottegård A,Kuiper J G,Booth H,Reutfors J,Calingaert B,Lund L C,Crellin E,Schmitt-Egenolf M,Kaye J A,Gembert K,Rothman K J,Kieler H,Dedman D,Houben E,Gutiérrez L,Hallas J,Perez-Gutthann S .2021 .Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus: Final results from the extension of the cohort study protopic joint european longitudinal lymphoma and skin cancer evaluation (JOELLE). Clin. Epidemiol, 13 : 1141-1153.
Bennardo F,Liborio F,Barone S,Antonelli A,Buffone C,Fortunato L,Giudice A .2021 .Efficacy of plateletrich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: A pilot study. Clin. Oral, 25(6) : 3747-3755.
Chen S,Wu X,Yang Y,Xu X,Xiong X,Meng W .2024 .Increased pathogenicity and pro-inflammatory capabilities of mucosal-associated invariant T cells involved in oral lichen planus. BMC Oral Health, 24(1) : 829.
DeAngelis LM,Cirillo N,Perez-Gonzalez A,McCullough M .2023 .Characterization of mucosalassociated invariant t cells in oral lichen planus. Int. J. Mol. Sci, 24(2) : 1490.
Didona D,Caposiena Caro R D F,Hertl M .2022 .Therapeutic strategies for oral lichen planus: State of the art and new insights. Front Med (Lausanne), 9 : 997190.
Djukic T,Drvenica I,Kovacic M,Milanovic S,Majeric D,Sefik-Bukilica M,Miletic M,Bugarski B,Ilić V .2024 .Exploring the link between hydrodynamic size and immunoglobulins of circulating immune complexes in rheumatoid arthritis patients. Int. J. Mol. Sci, 25(6) : 3138.
Elenbaas A,Enciso R,Al-Eryani K .2022 .Oral lichen planus: A review of clinical features, etiologies, and treatments. Dent. Rev., 2(1) : 100007.
ElGhareeb MI,Ghoneimy S,Elsayed A .2023 .Intralesional injection of platelet-rich plasma versus steroid in the treatment of oral lichen planus. J Cosmet. Dermatol., 22(5) : 1481-1487.
Godoi TTF,Rodrigues BL,Huber SC,Santana MHA,da Fonseca LF,Santos GS,Azzini GOM,Mosaner T,Paulus-Romero C,Lana JFSD C .2022 .Platelet-rich plasma gel matrix (PRP-GM): Description of a new technique. Bioengineering, 9(12) : 817.
Gonzalez-Moles M,Warnakulasuriya S,Gonzalez-Ruiz I,Gonzalez-Ruiz L,Ayen A,Lenouvel D,Ruiz-Ávila I,Ramos-García P .2021 .Worldwide prevalence of oral lichen planus: A systematic review and metaanalysis. Oral Dis, 27(4) : 813-828.
Guo CL,Zhao JZ,Zhang J,Dong HT .2015 .Efficacy of topical tacrolimus for erosive oral lichen planus: A meta-analysis. Chin. Med. Sci. J, 30(4) : 210-217.
Gururaj N,Hasinidevi P,Janani V,Divynadaniel T .2021 .Diagnosis and management of oral lichen planus - Review. , 25(3) : 383-393.
Hettiarachchi P,Hettiarachchi RM,Jayasinghe RD,Sitheeque M .2017 .Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double-blinded, randomized clinical trial in Sri Lanka. J. Investig. Clin. Dent., 8(4) : 12237.
Hijazi A,Ahmed W,Gaafar S W .2022 .Efficacy of intralesional injections of platelet-rich plasma in patients with oral lichen planus: A pilot randomized clinical trial. Clin. Exp. Dent Res., 8(3) : 707-714.
Huber SC,Sachetto A,Santos Z,Annichino-Bizzacchi Duarte Lana JF,JM Duarte Lana JF .2021 .Characterization of autologous platelet rich plasma (PRP) and its biological effects in patients with Behcet's disease. Regen. Ther., 18 : 339-346.
Ismail F F and Sinclair R .2020 .Clinical healing of erosive oral lichen planus with tildrakizumab implicates the interleukin-23/interleukin-17 pathway in the pathogenesis of lichen planus. Australas J. Dermatol., 61(2) : e244-e245.
Jain N K and Gulati M .2016 .Platelet-rich plasma: a healing virtuoso. Blood Res., 51(1) : 3-5.
Jiang L,Huang Y,Fang M,Chen X,Feng D,Liu J,Jiang Q,Tao R Q .2024 .Dynamic changes of Th1/Th2/Th17 cytokines and hBD-2/3 in erosive oral lichen planus patients saliva before and after prednisone acetate treatment. Heliyon, 10(1) : e24043.
Basirat Kia S J,Mortezaie M,Moosavi T,M S T .2020 .Comparison of oral nano-curcumin with oral prednisolone on oral lichen planus: A randomized double-blinded clinical trial. BMC Complement. Med, 20(1) : 328.
Li C,Tang X,Zheng X,Ge S,Wen H,Lin X,Chen Z,Lu L Z .2020 .Global prevalence and incidence estimates of oral lichen planus: A systematic review and meta-analysis. JAMA Dermatol, 156(2) : 172-181.
Lodi G,Manfredi M,Mercadante V,Murphy R,Carrozzo M .2020 .Interventions for treating oral lichen planus: Corticosteroid therapies. Cochrane Database Syst. Rev., 2(2) : Cd001168.
Louisy A,Humbert E,Samimi M .2024 .Oral lichen planus: An update on diagnosis and management. Am. J. Clin. Dermatol, 25(1) : 35-53.
Lu R,Zhang J,Sun W,Du G,Zhou G .2015 .Inflammation-related cytokines in oral lichen planus: An overview. J. Oral Pathol. Med, 44(1) : 1-14.
Ma W,Wei S,Long S,Tian E C,McLaughlin B,Jaimes M,Montoya D J,Viswanath V R,Chien J,Zhang Q .2023 .Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry. Front. Immunol., 14 : 1206631.
Maddheshiya N,Srivastava A,Rastogi V,Shekhar A,Sah N,Kumar A .2023 .Platelet-rich plasma protein as a therapeutic regimen for oral lichen planus: An evidence-based systematic review. Natl. J. Maxillofac Surg, 14(1) : 22-26.
Maehara T,Moriyama M,Kawano S,Hayashida J N,Furukawa S,Ohta M,Tanaka A,Yamauchi M,Ohyama Y,Kiyoshima T,Nakamura S T .2015 .Cytokine profiles contribute to understanding the pathogenic difference between good syndrome and oral lichen planus: Two case reports and literature review. Medicine (Baltimore), 94(14) : e704.
Merigo E,Oppici A,Parlatore A,Cella L,Clini F,Fontana M,Fornaini C M .2018 .Platelet-rich plasma (PRP) rinses for the treatment of non-responding oral lichen planus: a case report. Biomedicines, 6(1) : 15.
Fehervari Meznerics F A,Dembrovszky P,Kovacs F,Kemény K D,Csupor L V,Hegyi D,Banvölgyi P,A P .2022 .Platelet-rich plasma in chronic wound management: A systematic review and meta-analysis of randomized clinical trials. J. Clin. Med, 11(24) : 7532.
Mozaffari H R R,Sadeghi M .2018 .Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: A meta-analysis study. Cent. Eur. J. Immunol., 43(1) : 103-108.
Ozdemir S,Parlakyıldız Gokce A,Unver T .2020 .Simulation of three intraoral radiographic techniques in pediatric dental patients: Subjective comfort assessment using the VAS and Wong-Baker FACES Pain Raiting Scale. BMC Oral Health, 20 : 1-7.
Pinto J,Waghmare M,Bhor K,Santosh V,Manoj R,Samson S R .2023 .Efficacy and safety of topical tacrolimus in comparison with topical corticosteroids, calcineurin inhibitors, retinoids and placebo in oral lichen planus: An updated systematic review and metaanalysis. Asian Pac. J. Cancer Prev, 24(2) : 389-400.
Popovska M,Grchevska L,Popovski V,AtanasovskaStojanovska A,Minovska A,Belazelkoska Z,Radojkova-Nikolovska V,Mitik K,Strezovska S K .2013 .T-cell subpopulations in lesions of oral lichen planus. Pril (Makedon Akad Nauk Umet Odd Med Nauki), 34(2) : 143-149.
Qing M,Yang D,Shang Q,Peng J,Deng J,Lu J,Li J,Dan H,Zhou Y,Xu H,Chen Q H .2023 .CD8+ tissueresident memory T cells induce oral lichen planus erosion via cytokine network. Elife, 12 : e83981.
Rassol HJ,Zaidan TF .2023 .Immunohistochemical expression of T-cell subsets (CD4 and CD8) in oral lichen planus. Pan. Afr. Med, 45 : 147.
Rebora A .2017 .Tacrolimus and oral lichen planus: The question remains. J. Eur. Acad. Dermatol, 31(2) : e86.
Ribero S,Stieger M,Quaglino P,Hongang T,Bornstein M M,Naldi L,Borradori L L .2015 .Efficacy of topical tacrolimus for oral lichen planus: Real-life experience in a retrospective cohort of patients with a review of the literature. J. Eur. Acad. Dermatol, 29(6) : 1107-1113.
Sofineti Rotaru D I,Bolboaca S D and Bulboacă D,A E D .2020 .Diagnostic criteria of oral lichen planus: A narrative review. Acta Clin. Croat, 59(3) : 513-522.
Saglam E,Unver Z B,Alinca T,Toprak S B,Tunali A,M A .2021 .Efficacy of injectable plateletrich fibrin in the erosive oral lichen planus: A splitmouth, randomized, controlled clinical trial. J. Appl. Oral Sci., 29 : e20210180.
Sethi Ahuja U,Puri N,More C B,Gupta R,Gupta D R .2020 .Comparative evaluation of effectiveness of autologous platelet rich plasma and intralesional corticosteroids in the management of erosive oral Lichen planus - a clinical study. J. Oral Biol. Craniofac. Res., 10(4) : 714-718.
Shilpa PS,Kaul R,Bhat S,Sanjay CJ,Sultana N CJ .2014 .Topical tacrolimus in the management of oral lichen planus: Literature review. J. Calif. Dent. Assoc., 42(3) : 165-170.
Singh A,Khillan R,Mishra Y,Khurana S Y .2022 .The safety profile of COVID-19 vaccinations in the United States. Am. J. Infect. Control, 50(1) : 15-19.
Talaat Smith O J,Tomouk S,Jell T,Mosahebi G,A G .2022 .An evaluation of the effect of activation methods on the release of growth factors from plateletrich plasma. Plast. Reconstr. Surg, 149(2) : 404-411.
Sridharan K and Sivaramakrishnan G .2021 .Interventions for oral lichen planus: A systematic review and network meta-analysis of randomized clinical trials. Aust, 66(3) : 295-303.
Sriram S,Hasan S,Alqarni A,Alam T,Kaleem S M,Aziz S,Durrani H K M,Dawasaz A A,Saeed S A A .2023 .Efficacy of platelet-rich plasma therapy in oral lichen planus: A systematic review. Medicina (Kaunas), 59(4) : 746.
Su Z,Hu J,Cheng B,Tao X .2022 .Efficacy and safety of topical administration of tacrolimus in oral lichen planus: An updated systematic review and metaanalysis of randomized controlled trials. J. Oral Pathol. Med, 51(1) : 63-73.
Sun SL,Liu JJ,Zhong B,Wang JK,Jin X,Xu H,Yin FY,Liu T N,Chen Q M and Zeng X .2019 .Topical calcineurin inhibitors in the treatment of oral lichen planus: A systematic review and meta-analysis. Br. J. Dermatol., 181(6) : 1166-1176.
Thomson MA,Hamburger J,Stewart DG,Lewis HM .2004 .Treatment of erosive oral lichen planus with topical tacrolimus. J Dermatolog Treat., 15(5) : 308-314.
Utz S,Suter V G A,Cazzaniga S,Borradori L,Feldmeyer L L .2022 .Outcome and long-term treatment protocol for topical tacrolimus in oral lichen planus. J. Eur. Acad. Dermatol, 36(12) : 2459-2465.
Wang H,Zhang D,Han Q,Zhao X,Zeng X,Xu Y,Sun Z,Chen Q .2016 .Role of distinct CD4+ T helper subset in pathogenesis of oral lichen planus. J. Oral Pathol. Med, 45(6) : 385-393.
Wang K,Miao T,Lu W,He J,Cui B,Li J,Li Y,Xiao L Y .2015 .Analysis of oral microbial community and Th17-associated cytokines in saliva of patients with oral lichen planus. Microbiol, 59(3) : 105-113.
Wu T,Bai Y,Jing Y,Chen F Y .2024 .What can we learn from treatments of oral lichen planus? Front. Cell Infect. , 14 : 1279220.
Yang J Y,Tan Y Q and Zhou G .2022 .T cell-derived exosomes containing cytokines induced keratinocytes apoptosis in oral lichen planus. Oral Dis, 28(3) : 682-690.
Zhang Y,Liu K,Cheng J,Zhou C,Zhang M,Fan Y .2022 .FAP-α+ immunofibroblasts in oral lichen planus promote CD4+ T-cell infiltration via CCL5 secretion. , 31(9) : 1421-1430.
0

Citations

0

Downloads

101

Views